Predictive Oncology Inc (FRA:S1K)
€ 4 0 (0%) Market Cap: 11.84 Mil Enterprise Value: 3.66 Mil PE Ratio: 0 PB Ratio: 2.40 GF Score: 55/100

Q4 2022 Predictive Oncology Inc Earnings Call Transcript

Mar 22, 2023 / 04:00PM GMT
Release Date Price: €5.82 (-4.50%)
Operator

Good day, and thank you for standing by. Welcome to the Predictive Oncology Q4 2022 Earnings Conference Call. (Operator Instructions). Please be advised that today's conference is being recorded. And I would now like to hand the conference over to your speaker today, Ms. Theresa Ferguson, Senior Director of Marketing for Predictive Oncology. Ms. Ferguson, please go ahead.

Theresa Ferguson
Predictive Oncology Inc. - Senior Director of Marketing

Thank you. Welcome, and thank you, everyone, for dialing in. Today we'll share about our latest updates. First, you're going to hear from our Chief Executive Officer and Chairman of the Board, Raymond Vennare; then our Chief Financial Officer, Bob Myers, will give you an overview about our financials. Finally, Dr. Pamela Bush, our Chief Business Officer, will join Raymond and Bob during the Q&A portion.

Certain matters discussed in this call contain forward-looking statements. These forward-looking statements reflect our current expectations and projections about future events and are subject to substantial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot